GLPwatch
The facts on GLP-1 drugs, refreshed daily.
Ozempic, Wegovy, Mounjaro, and the other GLP-1 drugs: what each one treats, current shortages, reported side effects, and the latest research. All from official public records.
- 13branded drugs
- 15molecules tracked
- 2,036clinical trials
- 9,189research papers
- 181,907adverse-event reports
- Drugs FDA-approved branded products — labels, shortages, recalls.
- Molecules Approved and pipeline GLP-1 (and co-agonist) molecules.
- Conditions Approved and investigational indications.
- Side effects FAERS report counts and label-stated frequencies.
- Trials Active and recent GLP-1 clinical trials.
- Papers Top GLP-1 research by citation velocity.
- Compare Side-by-side: Ozempic vs Wegovy, and more.
- Pipeline Investigational molecules, sponsors, and trial counts.
- Compounding 503A/503B status and FDA enforcement.
- Manufacturers Products, pipeline, and SEC financials per maker.
- Leaderboards Most-cited research, top adverse events, shortages.
- News Daily changelog of detected data changes.